Kapil Cotex Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 ,inter alia, to consider and approve Consideration and approval of Unaudited ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Skybiotech Healthcare Ltd has informed BSE that its Board of Directors will meet on Friday, 14 November 2025. The main agenda item is to consider and approve the unaudited financial results along with the limited review report for the quarter ended 30 September 2025 (Q2 FY26). The intimation has been filed under Regulation 29(1)(a) of SEBI LODR Regulations 2015. The company has not disclosed any other specific business items like fundraising, dividend, or restructuring at this stage. Investors should watch for the results announcement post the meeting.
This is a routine regulatory filing with no immediate impact on the stock. Shareholders should await the Q2 FY26 results release on or after 14 November for clarity on the company's financial performance.